Trial Profile
Phase I study of intravenous artesunate (IV AS) in patients with solid tumours
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Jul 2015
Price :
$35
*
At a glance
- Drugs Artesunate (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 14 Jul 2015 New trial record
- 02 Jun 2015 Results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.